Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Free Report) reached a new 52-week high during mid-day trading on Friday . The company traded as high as $368.45 and last traded at $368.45, with a volume of 11 shares changing hands. The stock had previously closed at $334.85.
Bio-Rad Laboratories Stock Up 10.0 %
The firm has a market cap of $10.27 billion, a PE ratio of -12.25 and a beta of 0.73. The company has a current ratio of 6.14, a quick ratio of 4.52 and a debt-to-equity ratio of 0.16. The firm has a 50 day moving average price of $332.14 and a 200-day moving average price of $306.31.
About Bio-Rad Laboratories
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
See Also
- Five stocks we like better than Bio-Rad Laboratories
- 3 Tickers Leading a Meme Stock Revival
- Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- The Most Important Warren Buffett Stock for Investors: His Own
- The Top 5 Performing S&P 500 Stocks YTD in 2024
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
